Abiopharma

News list

Cramer Naomi 🟡 adjusted position in 255 shares (1 derivative) of Leslie's, Inc. (LESL) at $0.61 Transaction Date: Aug 26, 2026 | Filing ID: 371712

Full text

News bot Aug. 27, 2026, 10:49 p.m.
🔍 Cramer Naomi (Executive)

Company: Leslie's, Inc. (LESL)

Report Date: 2026-08-26
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,000
- Total shares sold: 1,255
Detailed Transactions and Holdings:
- Acquired 1,000 shares of Common Stock, par value $0.001 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: false | shares_owned_after: 10,378.00 | transaction_form_type: 4
- Sold 255 shares of Common Stock, par value $0.001 per share at $0.6063 per share (Direct)
  Date: 2026-08-26 | Code: F | equity_swap_involved: false | shares_owned_after: 10,123.00 | transaction_form_type: 4
- Sold 1,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: M | equity_swap_involved: false | shares_owned_after: 24,854.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock.
- F2: Represents a grant of RSUs which fully vested on August 26, 2026.
- REMARKS: Chief Retail Operations and Talent Officer